O=C1NCN(c2ccccc2)C12CCN(C(c1ccnc3ccccc13)c1nnnn1-c1ccc3c(c1)OCCO3)CC2
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?